keyword
https://read.qxmd.com/read/38634578/hemostatic-and-ultrasound-controlled-bactericidal-silk-fibroin-hydrogel-via-integrating-a-perfluorocarbon-nanoemulsion
#1
JOURNAL ARTICLE
Ruihao Yang, Haoran Zhang, Yumo Chen, Linxuan Zhang, Jing Chu, Kang Sun, Congli Yuan, Ke Tao
Excessive blood loss and infections are the prominent risks accounting for mortality and disability associated with acute wounds. Consequently, wound dressings should encompass adequate adhesive, hemostatic, and bactericidal attributes, yet their development remains challenging. This investigation presented the benefits of incorporating a perfluorocarbon nanoemulsion (PPP NE) into a silk-fibroin (SF)-based hydrogel. By stimulating the β-sheet conformation of the SF chains, PPP NEs drastically shortened the gelation time while augmenting the elasticity, mechanical stability, and viscosity of the hydrogel...
April 18, 2024: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/38633111/emicizumab-for-acquired-hemophilia-a-report-of-two-cases-and-dosing-strategies
#2
Faiza Ahmed, Mariia Kasianchyk, Alejandro Moreno, Simone Chang, Satish Maharaj
Acquired hemophilia A (AHA) is a rare autoimmune bleeding disorder caused by autoantibodies against FVIII. Severe AHA is life-threatening. Currently, licensed hemostatic agents for the treatment of severe AHA have short half-lives and require intravenous administration, leading to a need for hospitalization, higher costs, and negative effects on quality of life. We present two cases of severe AHA with high inhibitor titers where emicizumab was safely and effectively used with intensive immunosuppression...
April 2024: EJHaem
https://read.qxmd.com/read/38632502/risk-factors-for-relaparotomy-after-a-cesarean-delivery-a-case-control-study
#3
JOURNAL ARTICLE
Uri Amikam, Yael Botkovsky, Alyssa Hochberg, Aviad Cohen, Ishai Levin, Yariv Yogev, Liran Hiersch, Anat Lavie
BACKGROUND: Relaparotomy following a cesarean delivery (CD) is an infrequent complication, with inconsistency regarding risk factors and indications for its occurrence. We therefore aimed to determine risk factors and indications for a relaparotomy following a CD at a single large tertiary center. METHODS: A retrospective case-control single-center study (2013-2023). We identified all women who had a relaparotomy up to six weeks following a CD (study group). Maternal characteristics, obstetrical and surgical data were compared to a control group in a 1:2 ratio...
April 17, 2024: BMC Pregnancy and Childbirth
https://read.qxmd.com/read/38630370/aortoesophageal-fistula-due-to-esophageal-cancer-a-case-report-of-successful-management
#4
JOURNAL ARTICLE
Kohei Saisho, Naoki Mori, Masashi Nakagawa, Eiji Nakamura, Yu Tanaka, Hideaki Kaku, Yuya Tanaka, Taro Isobe, Hiroyuki Otsuka, Tomoya Sudo, Hisamune Sakai, Nobuya Ishibashi, Toru Hisaka, Eiki Tayama, Fumihiko Fujita
BACKGROUND: Aortoesophageal fistula (AEF) is a rare but potentially life-threatening condition. The best treatment for the AEF due to esophageal carcinoma is still unresolved. Here, we report a rare case of AEF caused by esophageal cancer, that was successfully treated with emergency thoracic endovascular aortic repair (TEVAR), followed by esophagectomy and gastric tube reconstruction. CASE PRESENTATION: A 64-year-old man presented with loss of consciousness and hypotension during chemoradiotherapy for advanced esophageal cancer...
April 17, 2024: Surgical Case Reports
https://read.qxmd.com/read/38630180/tavac-comprehensive-review-of-currently-available-hemostatic-products-as-adjunct-to-surgical-hemostasis
#5
JOURNAL ARTICLE
Iswanto Sucandy, Sharona Ross, Jonathan DeLong, Michael Tran, Fred Qafiti, David Pechman, Tim Snow, Salvatore Docimo, Allyson Lim-Dy, Maria Christodoulou, David Renton
BACKGROUND: The use of hemostatic agents by general surgeons during abdominal operations is commonplace as an adjunctive measure to minimize risks of postoperative bleeding and its downstream complications. Proper selection of products can be hampered by marginal understanding of their pharmacokinetics and pharmacodynamics. While a variety of hemostatic agents are currently available on the market, the choice of those products is often confusing for surgeons. This paper aims to summarize and compare the available hemostatic products for each clinical indication and to ultimately better guide surgeons in the selection and proper use of hemostatic agents in daily clinical practice...
April 17, 2024: Surgical Endoscopy
https://read.qxmd.com/read/38628503/-not-available
#6
Atsushi Kanamori, Yuji Nadatani, Nahoko Kushiyama, Akinobu Nakata, Akira Higashimori, Masaki Ominami, Tatsuo Kimura, Shinya Fukumoto, Yasuhiro Fujiwara, Toshio Watanabe
Esophageal submucosal hematoma is a rare, often incidental complication of therapeutic endoscopic procedures marked by disrupted blood vessels beneath the esophageal mucosa, forming a hematoma. We report the unique case of a severely thin and alcoholic 38-year-old woman with a history of reflux esophagitis who developed an esophageal submucosal hematoma during an unsedated transnasal endoscopy for health check-up. During the procedure, the patient experienced strong vomiting reflexes and vomited blood, leading to the initial suspicion of either Mallory-Weiss syndrome or epistaxis...
April 2024:
https://read.qxmd.com/read/38626592/is-there-a-role-for-the-laboratory-monitoring-in-the-management-of-specific-antidotes-of-direct-oral-anticoagulants
#7
REVIEW
Nicolas Gendron, Paul Billoir, Virginie Siguret, Véronique Le Cam-Duchez, Valérie Proulle, Laurent Macchi, Elodie Boissier, Christine Mouton, Emmanuel De Maistre, Isabelle Gouin-Thibault, Georges Jourdi
Given the growing number of patients receiving direct oral anticoagulant (DOAC), patients requiring rapid neutralization is also increasing in case of major bleedings or urgent surgery/procedures. Idarucizumab is commercialized as a specific antidote to dabigatran while andexanet alfa has gained the Food and Drug Administration and the European Medicines Agency approval as an oral anti-factor Xa inhibitors antidote. Other antidotes or hemostatic agents are still under preclinical or clinical development, the most advanced being ciraparantag...
April 10, 2024: Thrombosis Research
https://read.qxmd.com/read/38626344/multihydrogen-bond-modulated-polyzwitterionic-removable-adhesive-hydrogel-with-antibacterial-and-hemostatic-function-for-wound-healing
#8
JOURNAL ARTICLE
Meng Wei, Haihua Wang, Jingheng Wu, Dong Yang, Ke Li, Xuan Liu, Mengxi Wang, Bixia Lin, Zhigao Wang
Wound management is a major challenge worldwide, placing a huge financial burden on the government of every nation. Wound dressings that can protect wounds, accelerate healing, prevent infection, and avoid secondary damage continue to be a major focus of research in the health care and clinical communities. Herein, a novel zwitterionic polymer (LST) hydrogel incorporated with [2-(methacryloyloxy) ethyl] dimethyl-(3-sulfopropyl) ammonium hydroxide (SBMA), mussel-inspired N -[tris(hydroxymethyl)methyl] acrylamide (THMA), and lithium magnesium salt was prepared for functional wound dressings...
April 16, 2024: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/38620079/fitusiran-reduces-bleeding-in-factor-x-deficient-mice
#9
JOURNAL ARTICLE
Sebastien Verhenne, Genevieve McCluskey, Hortense Maynadié, Frédéric Adam, Caterina Casari, Laurence Panicot-Dubois, Lydie Crescence, Christophe Dubois, Cecile V Denis, Peter J Lenting, Olivier D Christophe
Factor X (FX)-deficiency is a rare bleeding disorder manifesting a bleeding tendency caused by low FX activity levels. We aimed to explore the use of fitusiran (an investigational siRNA that silences antithrombin expression) to increase thrombin generation and the in vivo hemostatic potential under conditions of FX-deficiency. We therefore developed a novel model of inducible FX-deficiency, generating mice expressing <1% FX activity and antigen (f10low-mice). Compared to control f10WT-mice, f10low-mice had 6- and 4-fold prolonged clotting times in Prothrombin Time- and activated Partial Prothrombin Time-assays, respectively (p<0...
April 15, 2024: Blood
https://read.qxmd.com/read/38616454/does-the-use-of-viscoelastic-hemostatic-assays-for-periprocedural-hemostasis-management-in-liver-disease-improve-clinical-outcomes
#10
JOURNAL ARTICLE
Suzanne Maynard, Elizabeth Marrinan, Lara Roberts, Simon Stanworth
Routine hemostasis parameters such as prothrombin time and fibrinogen are frequently abnormal in patients with chronic liver disease and have been demonstrated to be poor predictors for periprocedural bleeding. Alterations in procoagulant and anticoagulant factors in this population result in a state of rebalanced hemostasis, which is not reflected by routine hemostatic measures. Viscoelastic hemostatic assays (VHA) present a point of care measure of global hemostasis with an emerging role in guiding transfusion in the liver transplant setting...
March 19, 2024: Transfusion Medicine Reviews
https://read.qxmd.com/read/38614387/three-year-outcomes-of-valoctocogene-roxaparvovec-gene-therapy-for-hemophilia-a
#11
JOURNAL ARTICLE
Bella Madan, Margareth C Ozelo, Priyanka Raheja, Emily Symington, Doris V Quon, Andrew D Leavitt, Steven W Pipe, Gillian Lowe, Gili Kenet, Mark T Reding, Jane Mason, Michael Wang, Annette von Drygalski, Robert Klamroth, Susan Shapiro, Hervé Chambost, Amy L Dunn, Johannes Oldenburg, Sheng-Chieh Chou, Flora Peyvandi, Carolyn M Millar, Dane Osmond, Hua Yu, Ebony Dashiell-Aje, Tara M Robinson, Johnny Mahlangu
BACKGROUND: Valoctocogene roxaparvovec transfers a human factor VIII (FVIII) coding sequence into hepatocytes of people with severe hemophilia A to provide bleeding protection. OBJECTIVE: Present 3-year efficacy and safety in the multicenter, open-label, single-arm, phase 3 GENEr8-1 trial. METHODS: GENEr8-1 enrolled 134 adult males with severe hemophilia A who were receiving FVIII prophylaxis. Efficacy endpoints included annualized bleeding rate (ABR), annualized FVIII utilization (AFU), FVIII activity (chromogenic substrate assay; imputed as 1 IU/dL at baseline and 0 IU/dL after discontinuation), and the Haemophilia-Specific Quality of Life Questionnaire for Adults (Haemo-QOL-A)...
April 11, 2024: Journal of Thrombosis and Haemostasis: JTH
https://read.qxmd.com/read/38613795/therapeutic-effect-of-zno-nps-polyhexanide-hydrogel-on-staphylococcus-aureus-induced-skin-wound-infection-in-mice
#12
JOURNAL ARTICLE
Junhe Zhu, Yuxin Li, Yixin Tang, Yike Fan, Shiyi Dai, Awn Abbas, Funeng Xu, Xianxiang Wang, Wei Zhang, Yilei Zheng, Gang Shu
Nanometer zinc oxide (ZnONPs) offers strong antibacterial, wound healing, hemostatic benefits, and UV protection. Additionally, poly(hexamethylene biguanide)hydrochloride (PHMB) is an environmentally friendly polymer with strong bactericidal properties. However, the synergistic effect of the combination of ZnONPs and PHMB has not been previously explored. The purpose of this study is to explore the synergies of ZnONPs and PHMB and the healing efficacy of ZnO NPs-PHMB-hydrogel on skin wounds in mice infected with Staphylococcus aureus ...
April 13, 2024: Journal of Biomaterials Science. Polymer Edition
https://read.qxmd.com/read/38612205/clays-and-wound-healing
#13
REVIEW
Guangjian Tian, Zhou Wang, Zongwang Huang, Zuyan Xie, Lu Xia, Yi Zhang
Aluminosilicates, such as montmorillonite, kaolinite, halloysite, and diatomite, have a uniform bidimensional structure, a high surface-to-volume ratio, inherent stiffness, a dual charge distribution, chemical inertness, biocompatibility, abundant active groups on the surface, such as silanol (Si-OH) and/or aluminol (Al-OH) groups. These compounds are on the list of U.S. Food and Drug Administration-approved active compounds and excipients and are used for various medicinal products, such as wound healing agents, antidiarrheals, and cosmetics...
April 7, 2024: Materials
https://read.qxmd.com/read/38608460/preparation-of-antibacterial-hydrogel-from-poly-aspartic-hydrazide-and-quaternized-n-3-dimethylamino-propyl-methylacrylamide-copolymer-with-antioxidant-and-hemostatic-effects-for-wound-repairing
#14
JOURNAL ARTICLE
Yu Zhang, Junling Wang, Zhe Cui, Shuai Guo, Yong Wang, Wenjuan Li, Chengyan Zhou, Mingtao Run, Jianglei Qin
Hydrogels as wound dressing have attracted extensive attention in past decade because they can provide moist microenvironment to promote wound healing. Herein, this research designed a multifunctional hydrogel with antibacterial property and antioxidant activity fabricated from quaternary ammonium bearing light emitting quaternized TPE-P(DAA-co-DMAPMA) (QTPDD) and poly(aspartic hydrazide) (PAH). The protocatechuic aldehyde (PCA) grafted to the hydrogel through dynamic bond endowed the hydrogel with antioxidant activity and the tranexamic acid (TXA) was loaded to enhance the hemostatic performance...
March 28, 2024: Colloids and Surfaces. B, Biointerfaces
https://read.qxmd.com/read/38607180/electrospun-fenoprofen-polycaprolactone-tranexamic-acid-hydroxyapatite-nanofibers-as-orthopedic-hemostasis-dressings
#15
JOURNAL ARTICLE
Chang Huang, Menglong Wang, Siyou Yu, Deng-Guang Yu, Sim Wan Annie Bligh
Dressings with multiple functional performances (such as hemostasis, promoting regeneration, analgesia, and anti-inflammatory effects) are highly desired in orthopedic surgery. Herein, several new kinds of medicated nanofibers loaded with several active ingredients for providing multiple functions were prepared using the modified coaxial electrospinning processes. With an electrospinnable solution composed of polycaprolactone and fenoprofen as the core working fluid, several different types of unspinnable fluids (including pure solvent, nanosuspension containing tranexamic acid and hydroxyapatite, and dilute polymeric solution comprising tranexamic acid, hydroxyapatite, and polyvinylpyrrolidone) were explored to implement the modified coaxial processes for creating the multifunctional nanofibers...
April 8, 2024: Nanomaterials
https://read.qxmd.com/read/38605827/constitutive-hypercoagulability-in-pediatric-sickle-cell-disease-patients-with-hemoglobin-ss-genotype
#16
JOURNAL ARTICLE
Raizl G Sussman, Joy Mburu, MacGregor Steele, Annie Bang, Jeremy Friedman, Ran Goldman, Melanie Kirby, Margaret L Rand, Victor S Blanchette, Fred G Pluthero, Suzan Williams, Walter H A Kahr
BACKGROUND: Constitutive inflammation and hemostatic activation have been identified as key contributors to the pathophysiology of sickle cell disease (SCD), leading to clinical consequences such as vaso-occlusive crises and stroke. Patients with hemoglobin SS (HbSS) and hemoglobin SC (HbSC) genotypes are reported to have different symptoms, as do patients in steady-state and crisis situations. Differences among these groups remain unclear in pediatric patients. OBJECTIVES: To compare hemostatic activity in HbSS and HbSC pediatric patients during steady state, in crisis, and in clinical follow-up and compare HbSS and HbSC patients with normal healthy children...
March 2024: Research and Practice in Thrombosis and Haemostasis
https://read.qxmd.com/read/38605050/protein-disulfide-isomerase-cleaves-allosteric-disulfides-in-histidine-rich-glycoprotein-to-regulate-thrombosis
#17
JOURNAL ARTICLE
Keyu Lv, Shuai Chen, Xulin Xu, Joyce Chiu, Haoqing J Wang, Yunyun Han, Xiaodan Yang, Sheryl R Bowley, Hao Wang, Zhaoming Tang, Ning Tang, Aizhen Yang, Shuofei Yang, Jinyu Wang, Si Jin, Yi Wu, Alvin H Schmaier, Lining A Ju, Philip J Hogg, Chao Fang
The essence of difference between hemostasis and thrombosis is that the clotting reaction is a highly fine-tuned process. Vascular protein disulfide isomerase (PDI) represents a critical mechanism regulating the functions of hemostatic proteins. Herein we show that histidine-rich glycoprotein (HRG) is a substrate of PDI. Reduction of HRG by PDI enhances the procoagulant and anticoagulant activities of HRG by neutralization of endothelial heparan sulfate (HS) and inhibition of factor XII (FXIIa) activity, respectively...
April 11, 2024: Nature Communications
https://read.qxmd.com/read/38602463/the-natural-anticoagulant-protein-s-hemostatic-functions-and-deficiency
#18
REVIEW
Fahad S Alshehri, Abdullah A Bashmeil, Ibrahim A Alamar, Sarah K Alouda
Protein S (PS) is a vital endogenous anticoagulant. It plays a crucial role in regulating coagulation by acting as a cofactor for the activated protein C (APC) and tissue factor pathway inhibitor (TFPI) pathways. Additionally, it possesses direct anticoagulant properties by impeding the intrinsic tenase and prothrombinase complexes. Protein S oversees the coagulation process in both the initiation and propagation stages through these roles. The significance of protein S in regulating blood clotting can be inferred from the significant correlation between deficits in protein S and an elevated susceptibility to venous thrombosis...
December 2024: Platelets
https://read.qxmd.com/read/38601268/covered-self-expandable-metallic-stent-placement-for-tumor-bleeding-from-duodenal-invasion-in-patients-with-unresectable-pancreatic-cancer
#19
Taro Shibuki, Ko Fukushi, Kanae Inoue, Tomonao Taira, Tomoyuki Satake, Kazuo Watanabe, Mitsuhito Sasaki, Hiroshi Imaoka, Shuichi Mitsunaga, Masafumi Ikeda
Patients with unresectable pancreatic cancer often present with duodenal bleeding, a potentially life-threatening complication. In our case series of six unresectable pancreatic cancer patients with tumor bleeding, we explored the efficacy and safety of placement of a covered self-expandable metallic stent in the duodenum as a treatment option; we achieved a hemostasis rate of 67% (4/6), with a rebleeding rate of 50% (2/4). No complications occurred with stent placement, except for food impaction in one patient...
April 2024: DEN Open
https://read.qxmd.com/read/38601246/a-tie-over-hemostatic-approach-in-emergency-department-an-alternative-option-for-recurrent-episodes-of-postoperative-intraoral-hemorrhage
#20
JOURNAL ARTICLE
Ioannis Papadiochos, Paschalis Strantzias, Malamatenia Bourazani, Aikaterini Derila, Vasileios Petsinis
OBJECTIVE: This case series aimed to describe a hemostatic technique that has been applied in patients admitted to emergency department (ED) of a tertiary hospital due to recurrent episodes of intraoral hemorrhage (IOH) after various dentoalveolar operations. The "tie-over" approach involved the intraoral use of Xeroform® gauze (as compressive bolster dressing) and the oral rinsing with a liquid mixture of hemostatic agents. MATERIALS AND METHODS: Between February 1, 2014, and July 31, 2017, we retrospectively reviewed the medical data and records of patients in ED who chiefly complained about IOH...
April 2024: Journal of Maxillofacial and Oral Surgery
keyword
keyword
44928
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.